had achieved clear or almost clear skin, with 19.6% having no skin lesions at all week 16, rising to 26.2% after a year. Skyrizi – partnered with Boehringer Ingelheim – is already enjoying ...

Protagonist Therapeutics broke out Monday after the company's drug topped its rival from Bristol in a psoriasis study.

"Advances in our understanding of psoriatic disease have brought us to an era where clear skin is a realistic treatment goal. "Skyrizi has the potential to help psoriasis patients achieve high ...

(RTTNews) - AbbVie Inc. (ABBV) Tuesday said that its Skyrizi approved for the treatment of adults with moderately to severely active ulcerative colitis is now available in Canada. Ulcerative ...

UCB’s Bimzelx is firmly on physicians’ radars, with Spherix Global Insights finding that awareness of the drug was tracking ahead of AbbVie’s Rinvoq and Skyrizi three months into its ...